Filing Details
- Accession Number:
- 0001449374-16-000139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-31 14:19:03
- Reporting Period:
- 2016-03-29
- Filing Date:
- 2016-03-31
- Accepted Time:
- 2016-03-31 14:19:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1168220 | Uluru Inc. | ULUR | Pharmaceutical Preparations (2834) | 412118656 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1638122 | Centric Capital Ventures Llc | 590 Madison Avenue, Floor 18 New York NY 10022 | No | No | No | Yes | |
| 1638123 | J. Bradley Sacks | 590 Madison Avenue, Floor 18 New York NY 10022 | Yes | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-29 | 266,480 | $0.07 | 286,480 | No | 4 | P | Indirect | By Centric Capital Ventures LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Centric Capital Ventures LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Acquisiton | 2016-03-29 | 266,480 | $0.00 | 266,480 | $0.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 266,480 | 2016-03-30 | 2021-03-30 | No | 4 | P | Indirect |
Footnotes
- Under a Stock Purchase Agreement, dated as of March 29, 2016, with the Issuer and certain other investors, Centric Capital Ventures LLC ("Centric Capital") purchased 266,480 shares of the Issuer's Common Stock at a purchase price of $.0713 per share and was issued a warrant to purchase 266,480 shares of the Issuer's Common Stock (as reported in this Form 4) for no additional consideration.
Billionaire Hedge Funds
